Uncategorized
Nvidia, Amazon, Tesla, Palantir Among Top Beneficiaries Of $1 Trillion Saudi Arabia AI Push, Analyst Says
AI Revolution taking off in Saudi Arabia, creating major opportunities for US tech stocks. Trump’s visit & trade deal with China add to bullish outlook. read more
Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job creation across states. read more
American Eagle Slumps After Weak Q1 Preview, Analyst Cuts Forecasts On Demand Concerns
American Eagle shares tumble as analyst cuts FY25 outlook after weak Q1 update. Latest Ratings for AEO Date Firm Action From To Mar 2022 Morgan Stanley Maintains Equal-Weight Mar 2022 Deutsche Bank Maintains Buy Mar 2022 JP Morgan Maintains Overweight View More Analyst Ratings for AEO View the Latest Analyst Ratings read more
Musk, Bezos Gain Billions After US-China Trade Deal, But The Wealthiest 10 Are Still Down $67B In 2025
The top 10 richest people in the world are worth less than they were in 2024. Here’s a look at the gains and losses for top billionaires year-to-date. read more
Coinbase Explodes 47% Ahead Of S&P 500 Debut – Charts Flash Bullish Breakout
Coinbase (COIN) experiencing breakout moment, soaring 47% in past month due to S&P 500 inclusion and acquisition of Deribit. Technicals also strong. read more
CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up
CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public comments due by June 26. read more
FDA Fast-Tracks AbbVie’s New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases
FDA grants accelerated approval to AbbVie’s Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes $335 million upfront. read more
Bitcoin, Ethereum, XRP, Dogecoin Flat As Traders Hope For Altcoin Outperformance
Major cryptocurrencies are trading sideways amid stagnating Bitcoin dominance, potentially signaling increased capital rotation into altcoins. read more
FDA Approves Merck’s Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors
Merck’s Welireg wins FDA approval for rare PPGL tumors; Q1 2025 sales reach $137M, marking a 62% year-over-year increase. read more
